"Research Study to Compare a New Medicine Fast-acting Insulin Aspart to Another Medicine Insulin Aspart in Chinese People With Diabetes"

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

July 5, 2022

Study Completion Date

August 5, 2022

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

Faster aspart

Administered s.c. (subcutaneously, under the skin) for 16 weeks

DRUG

Insulin aspart

Administered s.c. (subcutaneously, under the skin) for 16 weeks

DRUG

Insulin degludec

Administered s.c. (subcutaneously, under the skin) for 16 weeks

Trial Locations (36)

53007

The Second Affiliated Hospital of Guangxi Medical University-Endocrinology, Nanning

100020

Beijing Chao-yang Hospital, Capital Medical University-Endocrinology, Beijing

100853

Chinese People's Liberation Army General Hospital-Endocrinology, Beijing

101200

Beijing Pinggu Hospital-Endocrinology, Beijing

130033

China-Japan Union Hospital of Jilin University-Endocrinology, Changchun

130041

The Second Hospital of Jilin University, Changchun

130061

The First Bethune hospital of Jilin University-Endocrinology, Changchun

200072

Shanghai Tenth People's Hsopital (Tenth People's of Tongji University)-Endocrinology, Shanghai

200240

Shanghai Fifth People's Hospital-Endocrinology, Shanghai

201199

Central Hospital of Minhang District-Endocrinology, Shanghai

210011

The Second Affiliated Hospital of Nanjing Medical University-Endocrinology, Nanjing

210029

Jiangsu Province Hospital, Nanjing

211199

Nanjing Jiangning Hospital-Endocrinology, Nanjing

212001

The Affiliated Hospital of Jiangsu University-Endocrinology, Zhenjiang

213003

Changzhou No.2 People's Hospital, Yanghu Branch, Changzhou

215002

Suzhou Municipal Hospital-Endocrinology, Suzhou

215006

The First Affiliated Hospital of Soochow University, Suzhou

230001

Anhui Provincial Hospital-Endocrinology, Hefei

230061

The First Affiliated Hospital of Anhui Medical University, Hefei

250013

Jinan Central Hospital, Ji'nan

300052

General Hospital of Tianjin Medical University-Endocrinology, Tianjin

330006

Jiangxi Provincial People's Hospital-Endocrinology, Nanchang

404000

Chongqing University Three Gorges Hospital, Chongqing

414000

Yueyang Central Hospital-Endocrinology, Yueyang

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen Universtiy, Guangzhou

515065

The Second Affiliated Hospital of Shantou University Medical College-Endocrinology, Shantou

650032

First Affiated Hospital of Kunming Medical University, Kunming

The First People's Hospital of Yunnan Province-Endocrinology, Kunming

650101

The Second Affiliated Hospital of Kunming Medical University, Kunming

810007

Qinghai Provincial People's Hospital, Xining

061000

Cangzhou People's Hospital-Endocrinology, Cangzhou

053000

Harrison International Peace Hospital-Endocrinology, Hengshui

050000

The Second Hospital of Hebei Medical University-Endocrinology, Shijiazhuang

063000

Tangshan Gongren Hospital, Tangshan

010020

Inner Mongolia People's Hospital-Endocrinology, Hohhot

010050

The affiliated hospital of Inner Mongolia Medical University, Hohhot

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY